Jyh-Pyng Gau
About
Jyh-Pyng Gau is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine.
According to data from OpenAlex, Jyh-Pyng Gau has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 16 papers in Genetics and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Jyh-Pyng Gau's work include Acute Myeloid Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Jyh-Pyng Gau is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Hematopoietic Stem Cell Transplantation (13 papers). Jyh-Pyng Gau collaborates with scholars based in Taiwan, United States and France. Jyh-Pyng Gau's co-authors include Tzeon-Jye Chiou, Liang-Tsai Hsiao, Cheng‐Hwai Tzeng, Rena Buckstein, Ching-Yuan Kuo, Xavier Thomas, Farhad Ravandi, Anna Dmoszyńska, Agnieszka Wierzbowska and Jiří Mayer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
In The Last Decade
Jyh-Pyng Gau
62 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jyh-Pyng Gau Taiwan | 16 | 1.0k | 562 | 415 | 379 | 299 | 62 | 1.7k | ||
| Oumédaly Reman France | 20 | 635 0.6× | 327 0.6× | 385 0.9× | 225 0.6× | 199 0.7× | 61 | 1.4k | ||
| Rita Rizzi Italy | 21 | 545 0.5× | 537 1.0× | 506 1.2× | 187 0.5× | 106 0.4× | 74 | 1.7k | ||
| Diane Coso France | 25 | 929 0.9× | 212 0.4× | 582 1.4× | 246 0.6× | 278 0.9× | 78 | 1.7k | ||
| Olivier Decaux France | 21 | 1.1k 1.1× | 872 1.6× | 559 1.3× | 340 0.9× | 44 0.1× | 78 | 1.8k | ||
| Norbert Frickhofen Germany | 18 | 1.0k 1.0× | 182 0.3× | 412 1.0× | 206 0.5× | 175 0.6× | 34 | 1.9k | ||
| Benedetto Comotti Italy | 14 | 573 0.6× | 334 0.6× | 317 0.8× | 225 0.6× | 66 0.2× | 29 | 1.2k | ||
| Tariq I. Mughal United States | 21 | 888 0.9× | 463 0.8× | 430 1.0× | 107 0.3× | 114 0.4× | 115 | 1.7k | ||
| Muhıt Özcan Türkiye | 21 | 673 0.7× | 231 0.4× | 944 2.3× | 254 0.7× | 107 0.4× | 174 | 2.0k | ||
| G. L. Phillips Canada | 20 | 931 0.9× | 265 0.5× | 507 1.2× | 168 0.4× | 366 1.2× | 47 | 1.6k | ||
| A Grañena Spain | 22 | 846 0.8× | 250 0.4× | 426 1.0× | 152 0.4× | 217 0.7× | 86 | 1.6k |
Countries citing papers authored by Jyh-Pyng Gau
Since
Specialization
Citations
This map shows the geographic impact of Jyh-Pyng Gau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyh-Pyng Gau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyh-Pyng Gau more than expected).
Fields of papers citing papers by Jyh-Pyng Gau
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jyh-Pyng Gau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyh-Pyng Gau. The network helps show where Jyh-Pyng Gau may publish in the future.
Co-authorship network of co-authors of Jyh-Pyng Gau
This figure shows the co-authorship network connecting the top 25 collaborators of Jyh-Pyng Gau. A scholar is included among the top collaborators of Jyh-Pyng Gau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyh-Pyng Gau. Jyh-Pyng Gau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chien, Sheng‐Hsuan, Ming Yao, Chi-Cheng Li, et al.. (2021). Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Journal of the Formosan Medical Association. 120(12). 2144–2152.
2.
Wang, Hao‐Yuan, Po‐Shen Ko, Chia‐Jen Liu, et al.. (2020). Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report. Journal of Medical Case Reports. 14(1). 43–43.
3.
Ko, Po‐Shen, Hao‐Yuan Wang, Chia‐Jen Liu, et al.. (2019). Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantation. Scientific Reports. 9(1). 11795–11795.
4.
Yang, Huai‐Che, Li-Yu Fay, Chiu-Mei Yeh, et al.. (2019). Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma. Journal of Cancer. 10(17). 3958–3966.
5.
Ko, Po‐Shen, Yuan-Bin Yu, Man‐Hsin Hung, et al.. (2017). Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib. Current Medical Research and Opinion. 33(10). 1737–1744.
6.
Hsiao, Liang-Tsai, Hao‐Yuan Wang, Tzeon-Jye Chiou, et al.. (2016). Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients. Medicine. 95(11). e3064–e3064.
7.
Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Yuan-Bin Yu, et al.. (2015). Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma. Journal of the Chinese Medical Association. 78(7). 400–407.
8.
Gau, Jyh-Pyng, Chih‐Cheng Chen, Chia‐Jen Liu, et al.. (2015). No increase of JAK2 46/1 haplotype frequency in essential thrombocythemia with CALR mutations: Functional effect of the haplotype limited to allele with JAK2V617F mutation but not CALR mutation. Blood Cells Molecules and Diseases. 55(1). 36–39.
9.
Wang, Hao‐Yuan, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). A “Bone Marrow Score” for Predicting Hematological Disease in Immunocompetent Patients With Fevers of Unknown Origin. Medicine. 93(27). e243–e243.
10.
Hsiao, Liang-Tsai, Tzeon-Jye Chiou, Jyh-Pyng Gau, et al.. (2014). Lymphocyte/monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B. Leukemia & lymphoma. 56(8). 2357–2364.
11.
Liu, Chun‐Yu, Hsueh‐Ju Lu, Man‐Hsin Hung, et al.. (2013). Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1513–1520.
12.
Kantarjian, Hagop M., Xavier Thomas, Anna Dmoszyńska, et al.. (2012). Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(21). 2670–2677.
13.
Liu, Chia‐Jen, Ying-Chung Hong, Shih-Hao Liu, et al.. (2011). Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification. Leukemia & lymphoma. 53(2). 289–294.
14.
Teng, Hao‐Wei, Ying-Chung Hong, Chun‐Yu Liu, et al.. (2011). International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents. Annals of Hematology. 91(1). 93–102.
15.
Liu, Chun‐Yu, Jyh-Pyng Gau, Liu H, et al.. (2011). Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes. Clinics. 66(12). 2055–2061.
16.
Yen, Chueh‐Chuan, et al.. (2010). A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone. Journal of Clinical Pharmacy and Therapeutics. 35(6). 733–736.
17.
Chen, Ming‐Huang, Tzeon-Jye Chiou, Peng-Chan Lin, et al.. (2007). Comparison of Myeloablative and Nonmyeloablative Hematopoietic Stem Cell Transplantation for Treatment of Chronic Myeloid Leukemia. International Journal of Hematology. 86(3). 275–281.
18.
Chen, Chih‐Cheng, Kuan‐Der Lee, Jyh-Pyng Gau, et al.. (2005). Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation. Annals of Hematology. 84(10). 675–680.
19.
Gau, Jyh-Pyng, Hui‐Chun Hsu, Wing‐Keung Chau, & Chao‐Hung Ho. (2003). A novel splicing acceptor mutation of the factor VIII gene producing skipping of exon 25. Annals of Hematology. 82(3). 175–177.
20.
Chen, Chih‐Cheng, et al.. (2003). Aggressive multiple myeloma with brain involvement in a young patient.. PubMed. 66(3). 177–80.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Oumédaly Reman Breakdown of academic impact, for papers by Rita Rizzi Breakdown of academic impact, for papers by Diane Coso Breakdown of academic impact, for papers by Olivier Decaux Breakdown of academic impact, for papers by Norbert Frickhofen Breakdown of academic impact, for papers by Benedetto Comotti Breakdown of academic impact, for papers by Tariq I. Mughal Breakdown of academic impact, for papers by Muhıt Özcan Breakdown of academic impact, for papers by G. L. Phillips Breakdown of academic impact, for papers by A Grañena